A University of Waterloo initiative described a real-time brain monitoring system intended for intensive care settings, aiming to flag infections earlier through continuous monitoring in patients with brain injuries. The platform is designed to reduce delays between symptom onset and actionable detection, with cost implications tied to shorter hospital episodes and improved workflow efficiency. Separately, Washington University in St. Louis researchers presented a portable bedside PET imaging system targeting real-time molecular imaging during interventional procedures, aiming to expand access to imaging decision-making directly at the point of care. Together, these moves emphasize operationally faster diagnostics—one via monitoring and one via molecular imaging—both designed to reduce lag time in critical care decision-making. For biotech and med-tech stakeholders, the focus is shifting from acquisition-to-readout timelines toward integration into clinical workflows and procedural decision points.